Recent advances in vaccine and immunotherapy research include Sophia Genetics' 16% revenue growth amid an expanded AstraZeneca breast cancer collaboration focused on AI-driven data integration to assess therapeutic value. Roche received FDA clearance for a multiplex respiratory viral test combining SARS-CoV-2, influenza, and RSV detection using enhanced PCR technology. Additionally, discoveries in bacteriophage targeting of extraintestinal E. coli clones and novel bacterial cancer treatments highlight the diversification of biologic approaches to infectious diseases and oncology.